Streptococcus pneumoniae (Spn) is a common cause of Community-Acquired Pneumonia (CAP) and Invasive Pneunmococcal Diseases (IPD). Risk for infection increases in particular in elderly. The aim of the study was to evaluate the introduction of 13-valent conjugate pneumococcal vaccine (PCV13) among patients ≥50 years.

Kheiraoui, F., De Waure, C., Specchia, M. L., Di Pietro, M. L., Mantovani, L., Capizzi, S., Cadeddu, C., Di Nardo, F., Ferriero, A. M., Veneziano, M. A., Furneri, G., Gualano, M. R., Nicolotti, N., Sferrazza, A., Refolo, P., Gliubizzi, M. D., Saulle, R., La Torre, G., Ricciardi, G., The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment, <<EUROPEAN JOURNAL OF PUBLIC HEALTH>>, 2013; (Settembre): 284-285. [doi:10.1093/eurpub/ckt124.117] [http://hdl.handle.net/10807/59716]

The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment

De Waure, Chiara;Specchia, Maria Lucia;Di Pietro, Maria Luisa;Capizzi, Silvio;Cadeddu, Chiara;Di Nardo, Francesco;Ferriero, Anna Maria;Veneziano, Maria Assunta;Gualano, Maria Rosaria;Nicolotti, Nicola;Sferrazza, Antonella;Refolo, Pietro;Gliubizzi, Maria Daniela;La Torre, Giuseppe;Ricciardi, Gualtiero
2013

Abstract

Streptococcus pneumoniae (Spn) is a common cause of Community-Acquired Pneumonia (CAP) and Invasive Pneunmococcal Diseases (IPD). Risk for infection increases in particular in elderly. The aim of the study was to evaluate the introduction of 13-valent conjugate pneumococcal vaccine (PCV13) among patients ≥50 years.
Inglese
Kheiraoui, F., De Waure, C., Specchia, M. L., Di Pietro, M. L., Mantovani, L., Capizzi, S., Cadeddu, C., Di Nardo, F., Ferriero, A. M., Veneziano, M. A., Furneri, G., Gualano, M. R., Nicolotti, N., Sferrazza, A., Refolo, P., Gliubizzi, M. D., Saulle, R., La Torre, G., Ricciardi, G., The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment, <<EUROPEAN JOURNAL OF PUBLIC HEALTH>>, 2013; (Settembre): 284-285. [doi:10.1093/eurpub/ckt124.117] [http://hdl.handle.net/10807/59716]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/59716
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact